1,650
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Survival benefit of surgical treatment for patients with stage IVB endometrial cancer: a propensity score-matched SEER database analysis

, &
Article: 2204937 | Received 07 Mar 2023, Accepted 16 Apr 2023, Published online: 12 May 2023

References

  • Albright, B.B., et al., 2021. Primary cytoreductive surgery for advanced stage endometrial cancer: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology, 225 (3), 237.e1–237.e24.
  • Alektiar, K.M., et al., 2003. Is endometrial carcinoma intrinsically more aggressive in elderly patients? Cancer, 98 (11), 2368–2377.
  • Antill, Y., et al., 2021. Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial. Journal for ImmunoTherapy of Cancer, 9 (6), e002255.
  • Ayhan, A., et al., 2002. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer. International Journal of Gynecologic Cancer, 12 (5), 448–453.
  • Bhambhvani, H.P., et al., 2021. Brain metastases from endometrial cancer: clinical characteristics, outcomes, and review of the literature. World Neurosurgery, 147, e32–e39.
  • Bogani, G., et al., 2022. Radiomics and molecular classification in endometrial cancer (The ROME Study): a step forward to a simplified precision medicine. Healthcare, 10 (12), 2464.
  • Brooks, R.A., et al., 2019. Current recommendations and recent progress in endometrial cancer. CA Cancer Journal for Clinicians, 69, 258–279.
  • Capozzi, V.A., et al., 2022. Predictive score of nodal involvement in endometrial cancer patients: a large multicentre series. Annals of Surgical Oncology, 29 (4), 2594–2599.
  • Casarin, J., et al., 2020. Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma. Journal of Gynecologic Oncology, 31 (5), e64.
  • Conway, J.L., et al., 2019. Clinical outcomes of surgically unresectable endometrial cancers. American Journal of Clinical Oncology, 42 (10), 777–782.
  • Crosbie, E.J., et al., 2022.  Endometrial cancer. Lancet, 399 (10333), 1412–1428.
  • Cuccu, I., et al., 2023. Role of genomic and molecular biology in the modulation of the treatment of endometrial cancer: narrative review and perspectives. Healthcare, 11 (4), 571.
  • Eggemann, H., et al., 2017. Management of elderly women with endometrial cancer. Gynecologic Oncology, 146 (3), 519–524.
  • Eto, T., et al., 2013. Status of treatment for the overall population of patients with stage IVb endometrial cancer, and evaluation of the role of preoperative chemotherapy: a retrospective multi-institutional study of 426 patients in Japan. Gynecologic Oncology, 131 (3), 574–580.
  • Fujimoto, T., et al., 2009. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence. Gynecologic Oncology, 112 (2), 342–347.
  • Giannini, A., et al., 2020. Predictors of postoperative overall and severe complications after surgical treatment for endometrial cancer: the role of the fragility index. International Journal of Gynaecology and Obstetrics, 148 (2), 174–180.
  • Gonzalez-Rodilla, I., et al., 2012. Patient age and biological aggressiveness of endometrial carcinoma. Anticancer Research., 32, 1817–1820.
  • Guo, J., et al., 2020. The clinical characteristics of endometrial cancer with extraperitoneal metastasis and the value of surgery in treatment. Technology in Cancer Research & Treatment, 19, 1533033820945784.
  • Havrilesky, L.J., et al., 2005. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecologic Oncology, 99 (3), 689–695.
  • Kitchener, H., et al., 2009. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet, 373, 125–136.
  • Klopp, A., et al., 2014. The role of postoperative radiation therapy for endometrial cancer: executive summary of an American Society for Radiation Oncology evidence-based guideline. Practical Radiation Oncology, 4 (3), 137–144.
  • Makker, V., et al., 2019. Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial. The Lancet. Oncology, 20 (5), 711–718.
  • Monaco, E., et al., 2008. Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery. Cancer, 113 (9), 2610–2614.
  • Morice, P., et al., 2016. Endometrial cancer. Lancet, 387 (10023), 1094–1108.
  • Multinu, F., et al., 2019. Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: comparison of comprehensive surgical staging and sentinel lymph node algorithm. Gynecologic Oncology, 155 (2), 177–185.
  • Nagle, C.M., et al., 2018. Endometrial cancer risk and survival by tumor MMR status. Journal of Gynecologic Oncology, 29 (3), e39.
  • NCCN., 2022. Clinical Practice Guidelines in Oncology, Uterine Neoplasms Version 1. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1473 [Accessed 4 November 2021].
  • Nout, R.A., et al., 2010. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet, 375 (9717), 816–823.
  • Rajkumar, S., et al., 2019. Advanced stage (IIIC/IV) endometrial cancer: role of cytoreduction and determinants of survival. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 234, 26–31.
  • Restaino, S., et al., 2022. Anatomical distribution of sentinel lymph nodes in patients with endometrial cancer: a multicenter study. International Journal of Gynecological Cancer, 32 (4), 517–524.
  • Ribeiro, R., et al., 2020. Brazilian Society of Surgical Oncology guidelines for surgical treatment of endometrial cancer in regions with limited resources. Journal of Surgical Oncology, 121, 730–742.
  • Rossi, E.C., et al., 2017. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. The Lancet. Oncology, 18 (3), 384–392.
  • Roudko, V., et al., 2020. Shared immunogenic poly-epitope frameshift mutations in microsatellite unstable tumors. Cell, 183 (6), 1634–1649.e17.
  • Shih, K.K., et al., 2011. Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecologic Oncology, 122 (3), 608–611.
  • Sorolla, M.A., Parisi, E. and Sorolla, A., 2020. Determinants of sensitivity to radiotherapy in endometrial cancer. Cancers, 12 (7), 1906.
  • Sozzi, G., et al., 2020. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study – a multicentric analysis of predictors of failed mapping. International Journal of Gynecological Cancer, 30 (11), 1713–1718.
  • Straubhar, A.M., et al., 2021. Refusal of surgery and survival outcomes in endometrial cancer. International Journal of Gynecological Cancer, 31 (9), 1236–1241.
  • Tanioka, M., et al., 2010. Clinical characteristics and outcomes of women with stage IV endometrial cancer. Medical Oncology, 27 (4), 1371–1377.
  • Todo, Y., et al., 2010. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet, 375 (9721), 1165–1172.
  • Tung, H.J., Huang, H.J. and Lai, C.H., 2022. Adjuvant and post-surgical treatment in endometrial cancer. Best Practice & Research, 78, 52–63.
  • Uccella, S., et al., 2016. Primary brain metastases of endometrial cancer: a report of 18 cases and review of the literature. Gynecologic Oncology, 142 (1), 70–75.
  • Ueda, Y., et al., 2010. Endometrial carcinoma with extra-abdominal metastasis: improved prognosis following cytoreductive surgery. Annals of Surgical Oncology, 17 (4), 1111–1117.
  • Vandenput, I., et al., 2009. Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment? British Journal of Cancer, 101 (2), 244–249.
  • Wang, H.Y., et al., 2016. Cancers screening in an asymptomatic population by using multiple tumour markers. PLoS One, 11 (6), e0158285.
  • Wang, J., et al., 2022. Bone metastases of endometrial carcinoma treated by surgery: a report on 13 patients and a review of the medical literature. International Journal of Environmental Research and Public Health, 19 (11), 6823.
  • Winarto, H., et al., 2022. Adjuvant chemoradiotherapy versus chemotherapy or radiotherapy in advanced endometrial cancer: a systematic review and meta-analysis. PeerJ., 10, e14420.